ESR1 and breast cancer: Triple-negative breast cancer (TNBC), a specific subtype of mammary cancer that is characterized by negative expression of estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), is prone to metastasis [125].